Novo Nordisk A/S (NVO)
38.66
-0.98
(-2.46%)
USD |
NYSE |
Feb 24, 14:30
Novo Nordisk Market Cap : 171.89B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 14.37B |
| Evaxion AS | 27.02M |
| Regeneron Pharmaceuticals, Inc. | 81.84B |
| Viking Therapeutics, Inc. | 3.922B |
| DBV Technologies SA | 1.202B |
Market Cap Related Metrics
| PE Ratio | 11.15 |
| PS Ratio | 3.681 |
| PEG Ratio | 1.974 |
| Price to Book Value | 7.431 |
| Price to Free Cash Flow | 39.09 |
| Price | 38.66 |
| Earnings Yield | 8.97% |
| PEGY Ratio | 1.114 |
| Operating PE Ratio | 8.940 |
| Normalized PE Ratio | 11.15 |